genisi - In late March the FDA had some questions about their new drug application. The price of the stock was more than cut in half. Now they have answered the questions and are going back at the FDA...there is a countdown to either success of failure in the wings. Success means an immediate double and failure means ENCY pretty much stays down here until they get it right.
I have not had time to update the i-box but go to yahoo and read the PRs from 25 March...